Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (121-130 of 305) with videos related to

Pageof 31
Sort By:
Journal of the American College of Cardiology|August 13, 2016
Standardization of Fractional Flow Reserve MeasurementsGabor G Toth, Nils P Johnson, Allen Jeremias, et al.
European Heart Journal|August 30, 2020
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trialPascal Vranckx, Marco Valgimigli, Lars Eckardt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2009
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CADPatrick W Serruys, Pascal Vranckx, Ton Slagboom, et al.
JACC. Cardiovascular Interventions|May 21, 2011
Autopsy validation study of the academic research consortium stent thrombosis definitionDonald E Cutlip, Gaku Nakazawa, Mitchell W Krucoff, et al.
Acta Cardiologica|December 13, 2017
Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI databaseMarc J Claeys, Peter R Sinnaeve, Carl Convens, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2020
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromesAnna Franzone, Eugène P McFadden, Sergio Leonardi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2021
Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyondRutao Wang, Sijing Wu, Amr Gamal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findingsMarco Valgimigli, Paul Steendijk, Patrick W Serruys, et al.
American Heart Journal|September 2, 2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trialNicolas M Van Mieghem, Martin Unverdorben, Marco Valgimigli, et al.
Circulation|October 24, 2023
One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical TrialRoberto Galea, Nicolas Meneveau, Federico De Marco, et al.
Pageof 31

Showing results (121-130 of 305) with videos related to

Sort By:
Pageof 31
Journal of the American College of Cardiology|August 13, 2016
Standardization of Fractional Flow Reserve MeasurementsGabor G Toth, Nils P Johnson, Allen Jeremias, et al.
European Heart Journal|August 30, 2020
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trialPascal Vranckx, Marco Valgimigli, Lars Eckardt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2009
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CADPatrick W Serruys, Pascal Vranckx, Ton Slagboom, et al.
JACC. Cardiovascular Interventions|May 21, 2011
Autopsy validation study of the academic research consortium stent thrombosis definitionDonald E Cutlip, Gaku Nakazawa, Mitchell W Krucoff, et al.
Acta Cardiologica|December 13, 2017
Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI databaseMarc J Claeys, Peter R Sinnaeve, Carl Convens, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2020
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromesAnna Franzone, Eugène P McFadden, Sergio Leonardi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2021
Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyondRutao Wang, Sijing Wu, Amr Gamal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Use of Impella Recover(R) LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findingsMarco Valgimigli, Paul Steendijk, Patrick W Serruys, et al.
American Heart Journal|September 2, 2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trialNicolas M Van Mieghem, Martin Unverdorben, Marco Valgimigli, et al.
Circulation|October 24, 2023
One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical TrialRoberto Galea, Nicolas Meneveau, Federico De Marco, et al.
Pageof 31